ClinicalTrials.gov record
Completed Phase 1 Interventional

Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2

ClinicalTrials.gov ID: NCT00000316

Public ClinicalTrials.gov record NCT00000316. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 11:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Human Dopamine Transported Imaging in Cocaine Abuse: 2

Study identification

NCT ID
NCT00000316
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute on Drug Abuse (NIDA)
NIH
Enrollment
Not listed

Conditions and interventions

Interventions

  • Cocaine Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 45 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 1996
Primary completion
Not listed
Completion
Nov 30, 2001
Last update posted
Jan 11, 2017

1996 – 2001

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Johns Hopkins University Baltimore Maryland 21287

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000316, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000316 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →